APA (7th ed.) Citation

Chen, W., Chen, W., Yoshida, S., Miura, N., Fukuda, S., Fukushima, H., . . . Fujii, Y. Effectiveness and safety of pembrolizumab, nivolumab, and atezolizumab as adjuvant therapy for high-risk muscle-invasive urothelial carcinoma: An indirect comparison. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Chen, Wei, Wei Chen, Soichiro Yoshida, Noriyoshi Miura, Shohei Fukuda, Hiroshi Fukushima, Yuma Waseda, Hajime Tanaka, and Yasuhisa Fujii. Effectiveness and Safety of Pembrolizumab, Nivolumab, and Atezolizumab as Adjuvant Therapy for High-risk Muscle-invasive Urothelial Carcinoma: An Indirect Comparison. Frontiers Media S.A.

MLA (9th ed.) Citation

Chen, Wei, et al. Effectiveness and Safety of Pembrolizumab, Nivolumab, and Atezolizumab as Adjuvant Therapy for High-risk Muscle-invasive Urothelial Carcinoma: An Indirect Comparison. Frontiers Media S.A.